Multi-targeted drug design strategies for the treatment of schizophrenia

Taylor and Francis Group, Expert Opinion on Drug Discovery, 1(16), p. 101-114, 2020

Journal article published in 2020 by Piotr Stępnicki

Distributing this paper is prohibited by the publisher

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by